CNTB
Connect Biopharma Holdings Ltd
NASDAQ: CNTB · HEALTHCARE · BIOTECHNOLOGY
$2.53
+5.42% today
Updated 2026-04-29
Market cap
$142.43M
P/E ratio
—
P/S ratio
2,225.53x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $4
Volume
0.3M
Connect Biopharma Holdings Ltd (CNTB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 7
Last 7 quarters
Avg EPS surprise
-8.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-41.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.0%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+14.1%
2026-04-01
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-01 | $-0.27 | — | $2.62 | $2.99 | +14.1% |
| 2025-12-31 | $-0.27 | +10.0% | $2.70 | $2.52 | -6.7% |
| 2025-12-03 | $-0.31 | -31.9% | $2.66 | $2.54 | -4.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-0.27 | — | — | — |
| 2025-12-31 | $-0.30 | $-0.27 | +10.0% | $16000.00 | -97.7% |
| 2025-09-30 | $-0.24 | $-0.31 | -31.9% | $16000.00 | — |
| 2025-06-30 | $-0.22 | $-0.23 | -4.5% | $48000.00 | — |
| 2025-03-31 | $-0.26 | $-0.19 | +26.9% | — | — |
| 2024-12-31 | $0.00 | $-0.42 | — | $698000.00 | — |
| 2023-06-30 | $-6.92 | $-0.54 | +92.2% | — | — |
Frequently asked questions
Has Connect Biopharma Holdings Ltd beaten earnings estimates?
Connect Biopharma Holdings Ltd has beaten Wall Street EPS estimates in 3 of its last 7 quarterly reports, with an average EPS surprise of -8.8% over the last 3 quarters.
How does CNTB stock react to earnings?
CNTB stock has moved an average of +1.0% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.